An amniotic fluid embolism (AFE) remains one of the most devastating conditions in obstetric practice. In today’s episode, Sass and Jeremy review the pathophysiology, signs and symptoms, and management of this rare, but lethal condition. Included in the management of an AFE is the administration of a trio of medications known as A-OK (Atropine, Ondansetron, and Ketorolac). If you want to brush up on current management techniques for an AFE, hit play…because it’s go time! Here are some of the things we’ll discuss in this episode: An example of this happening recently where Jeremy works. How the body reacts when an amniotic fluid embolism occurs. Who is most at risk for developing AFE? Signs and symptoms to pay attention to. The treatment and management of a patient suffering from AFE. What is the AOK treatment? About our hosts: https://kpatprogram.org/about-the-school/faculty.html Visit us online: http://beyondthemaskpodcast.com Get the CE certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related